Overview
Ternary Therapeutics, a London-based biotechnology company, has raised €4.1 million (£3.6 million) in a seed funding round to enhance its AI-powered platform for drug discovery. The round was led by Daphni, with participation from Pace Ventures, the I&I Biotech Fund, and the UK Innovation & Science Seed Fund (UKI2S). The funding will help scale the platform and accelerate the development of molecular glue therapeutics.
Products
Loading...
Recent Deals
$4.428M
Investors: Daphni, Pace Ventures, I&I Biotech Fund, UK Innovation & Science Seed Fund
Ternary Therapeutics, a London-based biotechnology company, has raised €4.1 million (£3.6 million) in a seed funding round to enhance its AI-powered platform for drug discovery. The round was led by Daphni, with participation from Pace Ventures, the I&I Biotech Fund, and the UK Innovation & Science Seed Fund (UKI2S). The funding will help scale the platform and accelerate the development of molecular glue therapeutics.